MuftuogluIKUnsalEOzturkerZk. Restoration of photoreceptors in eyes with diabetic macular edema. Eur J Ophthalmol2017;27(5):585-590.
2.
CălugăruDCălugăruM. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2017;255(7):1451-1452.
3.
CălugăruDCălugăruM. Pro-permeability factors in diabetic macular edema; the diabetic macular edema treated with Ozurdex trial. Am J Ophthalmol. 2016;170(4):244-245.
4.
CălugăruDCălugăruM. Comments to: Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema. Eur J Ophthalmol. 2016;26(6):e171-e172.
5.
CălugăruDCălugăruM. Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema. Am J Ophthalmol. 2016;168(2):290-291.